Antinuclear Antibody Test Market | Key Trends and Forecast to 2024

Antinuclear Antibody Test Market Overview:

Antinuclear Antibody Test Market value was worth USD 1169.4 million in 2019 and expected to reach USD 2109.5 million by 2024 at a CAGR of 12.52%. The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary test to check a person’s autoimmune disorders. Autoimmune disorders can affect many tissues and organs in the body. This test is most often used to diagnose the

Antinuclear Antibody Test Market Drivers and Restraints:

Factors such as an increase in the prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, and growth in the awareness of people about these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. According to WHO, from 1980 to 2014 number of people suffering from diabetes has increased from 108 million to 422 million and is expected to grow at the same rate in near future. Other factors such as, increase in healthcare expenditure of people due to growing economies, and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as diagnostic errors, product approval, and unavailability of skilled labor are hindering the growth of this market.

To know more, click on the link below:

https://www.marketdataforecast.com/market-reports/antinuclear-antibody-test-market